Raleigh, NC, United States of America

Jicheng Yu

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations in Insulin Delivery: The Work of Jicheng Yu

Introduction

Jicheng Yu is a prominent inventor based in Raleigh, NC, known for his significant contributions to the field of biomedical engineering. He has been instrumental in developing innovative solutions for insulin delivery, particularly for diabetes management. With a total of five patents to his name, Yu's work focuses on advanced drug delivery systems that enhance patient care.

Latest Patents

Among his latest patents, Yu has developed microneedle-array patches with a glucose-responsive matrix for closed-loop insulin delivery. This invention includes compositions and methods for microneedle patches that utilize a copolymer designed for glucose-triggered insulin delivery. The microneedle patches comprise insulin-loaded copolymers, which release insulin in a hyperglycemic environment. Another notable patent is the insulin-responsive glucagon delivery patch. This composition features an insulin-polymer conjugate and an insulin aptamer-glucagon conjugate, allowing for glucagon delivery in response to insulin levels in the surrounding environment.

Career Highlights

Jicheng Yu is affiliated with North Carolina State University, where he continues to advance research in drug delivery systems. His innovative approaches have garnered attention in the scientific community, contributing to the development of more effective diabetes management tools.

Collaborations

Yu has collaborated with notable researchers, including Zhen Gu and Guojun Chen, to further enhance the impact of his inventions in the field of biomedical engineering.

Conclusion

Jicheng Yu's work exemplifies the intersection of innovation and healthcare, particularly in the realm of diabetes management. His patents reflect a commitment to improving patient outcomes through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…